LYEL stock news
This page provides real-time market news, earnings updates, and company announcements related to Lyell Immunopharma, Inc. (LYEL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-16 01:28 EST
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma
Finviz2026-02-12 12:36:09
Lyell Immunopharma, Inc. (Lyell) announced that dosing has begun for patients with aggressive large B-cell lymphoma in a groundbreaking Phase 3 clinical trial.
老虎证券2026-02-12 12:42:49
LYEL stock chart
LYEL stock detailsLYEL stock price change
On the last trading day, LYEL stock closed at 25.84 USD, with a price change of 1.81% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more